213 related articles for article (PubMed ID: 30226596)
1. P2Y2R-mediated inflammasome activation is involved in tumor progression in breast cancer cells and in radiotherapy-resistant breast cancer.
Jin H; Ko YS; Kim HJ
Int J Oncol; 2018 Nov; 53(5):1953-1966. PubMed ID: 30226596
[TBL] [Abstract][Full Text] [Related]
2. NLRC4, ASC and Caspase-1 Are Inflammasome Components that Are Mediated by P2Y
Jin H; Kim HJ
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397236
[TBL] [Abstract][Full Text] [Related]
3. P2Y2 receptor activation by nucleotides released from highly metastatic breast cancer cells increases tumor growth and invasion via crosstalk with endothelial cells.
Jin H; Eun SY; Lee JS; Park SW; Lee JH; Chang KC; Kim HJ
Breast Cancer Res; 2014 Aug; 16(5):R77. PubMed ID: 25156554
[TBL] [Abstract][Full Text] [Related]
4. P2Y2R activation by nucleotides released from the highly metastatic breast cancer cell MDA-MB-231 contributes to pre-metastatic niche formation by mediating lysyl oxidase secretion, collagen crosslinking, and monocyte recruitment.
Joo YN; Jin H; Eun SY; Park SW; Chang KC; Kim HJ
Oncotarget; 2014 Oct; 5(19):9322-34. PubMed ID: 25238333
[TBL] [Abstract][Full Text] [Related]
5. P2Y
Jin H; Ko YS; Park SW; Kim HJ
Free Radic Biol Med; 2019 May; 136():109-117. PubMed ID: 30959169
[TBL] [Abstract][Full Text] [Related]
6. P2Y2 nucleotide receptor-mediated extracellular signal-regulated kinases and protein kinase C activation induces the invasion of highly metastatic breast cancer cells.
Eun SY; Ko YS; Park SW; Chang KC; Kim HJ
Oncol Rep; 2015 Jul; 34(1):195-202. PubMed ID: 26063340
[TBL] [Abstract][Full Text] [Related]
7. P2Y
Jin H; Ko YS; Yun SP; Park SW; Kim HJ
Int J Oncol; 2023 Jun; 62(6):. PubMed ID: 37165911
[TBL] [Abstract][Full Text] [Related]
8. Radioresistant breast cancer cells exhibit increased resistance to chemotherapy and enhanced invasive properties due to cancer stem cells.
Ko YS; Jin H; Lee JS; Park SW; Chang KC; Kang KM; Jeong BK; Kim HJ
Oncol Rep; 2018 Dec; 40(6):3752-3762. PubMed ID: 30272295
[TBL] [Abstract][Full Text] [Related]
9. Extracellular ATP and Purinergic P2Y
Schulien I; Hockenjos B; van Marck V; Ayata CK; Follo M; Thimme R; Hasselblatt P
Cancer Res; 2020 Feb; 80(4):699-708. PubMed ID: 31822494
[TBL] [Abstract][Full Text] [Related]
10. Regulation of CD39 expression in ATP-P2Y2R-mediated alcoholic liver steatosis and inflammation.
Liu ZN; Jia WQ; Jiang T; Dai JW; Shuai C; Lv XW
Int Immunopharmacol; 2019 Dec; 77():105915. PubMed ID: 31639617
[TBL] [Abstract][Full Text] [Related]
11. Activation of the P2Y
Orriss IR; Guneri D; Hajjawi MOR; Shaw K; Patel JJ; Arnett TR
J Endocrinol; 2017 Jun; 233(3):341-356. PubMed ID: 28420708
[TBL] [Abstract][Full Text] [Related]
12. P2Y
Thorstenberg ML; Martins MDA; Figliuolo V; Silva CLM; Savio LEB; Coutinho-Silva R
Mediators Inflamm; 2020; 2020():2545682. PubMed ID: 33061823
[TBL] [Abstract][Full Text] [Related]
13. [Identification of a new pro-invasion factor in tumor microenvironment: progress in function and mechanism of extracellular ATP].
Fang WG; Tian XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 49(2):188-195. PubMed ID: 28416823
[TBL] [Abstract][Full Text] [Related]
14. ATP-P2Y2-β-catenin axis promotes cell invasion in breast cancer cells.
Zhang JL; Liu Y; Yang H; Zhang HQ; Tian XX; Fang WG
Cancer Sci; 2017 Jul; 108(7):1318-1327. PubMed ID: 28474758
[TBL] [Abstract][Full Text] [Related]
15. The P2Y2 nucleotide receptor mediates the proliferation and migration of human hepatocellular carcinoma cells induced by ATP.
Xie R; Xu J; Wen G; Jin H; Liu X; Yang Y; Ji B; Jiang Y; Song P; Dong H; Tuo B
J Biol Chem; 2014 Jul; 289(27):19137-49. PubMed ID: 24847054
[TBL] [Abstract][Full Text] [Related]
16. Psychological Stress Activates the Inflammasome via Release of Adenosine Triphosphate and Stimulation of the Purinergic Type 2X7 Receptor.
Iwata M; Ota KT; Li XY; Sakaue F; Li N; Dutheil S; Banasr M; Duric V; Yamanashi T; Kaneko K; Rasmussen K; Glasebrook A; Koester A; Song D; Jones KA; Zorn S; Smagin G; Duman RS
Biol Psychiatry; 2016 Jul; 80(1):12-22. PubMed ID: 26831917
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-1 Regulates the P2Y2 Receptor Signaling in Human 1321N1 Astrocytoma Cells.
Martinez NA; Ayala AM; Martinez M; Martinez-Rivera FJ; Miranda JD; Silva WI
J Biol Chem; 2016 Jun; 291(23):12208-22. PubMed ID: 27129210
[TBL] [Abstract][Full Text] [Related]
18. P2Y
Khalafalla FG; Greene S; Khan H; Ilves K; Monsanto MM; Alvarez R; Chavarria M; Nguyen J; Norman B; Dembitsky WP; Sussman MA
Circ Res; 2017 Nov; 121(11):1224-1236. PubMed ID: 28923792
[TBL] [Abstract][Full Text] [Related]
19. IL-1β enhances vascular smooth muscle cell proliferation and migration via P2Y2 receptor-mediated RAGE expression and HMGB1 release.
Eun SY; Ko YS; Park SW; Chang KC; Kim HJ
Vascul Pharmacol; 2015 Sep; 72():108-17. PubMed ID: 25956731
[TBL] [Abstract][Full Text] [Related]
20. The purinergic receptor subtype P2Y2 mediates chemotaxis of neutrophils and fibroblasts in fibrotic lung disease.
Müller T; Fay S; Vieira RP; Karmouty-Quintana H; Cicko S; Ayata K; Zissel G; Goldmann T; Lungarella G; Ferrari D; Di Virgilio F; Robaye B; Boeynaems JM; Blackburn MR; Idzko M
Oncotarget; 2017 May; 8(22):35962-35972. PubMed ID: 28415591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
